HRT Financial’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-73,577
Closed -$937K 2575
2025
Q1
$937K Sell
73,577
-4,565
-6% -$83K 0.01% 1138
2024
Q4
$1.47M Buy
78,142
+22,847
+41% +$471K 0.01% 880
2024
Q3
$1.07M Buy
+55,295
New +$1.35M 0.01% 1203
2024
Q1
Sell
-8,091
Closed -$247K 2284
2023
Q4
$247K Sell
8,091
-6,871
-46% -$182K ﹤0.01% 1700
2023
Q3
$402K Sell
14,962
-65,577
-81% -$2.01M ﹤0.01% 1523
2023
Q2
$2.87M Buy
80,539
+64,693
+408% +$2.23M 0.03% 465
2023
Q1
$402K Buy
+15,846
New +$498K ﹤0.01% 1535
2022
Q3
Sell
-25,521
Closed -$898K 2770
2022
Q2
$898K Buy
+25,521
New +$960K 0.01% 1029
2021
Q4
Sell
-33,301
Closed -$2.08M 3150
2021
Q3
$2.08M Sell
33,301
-7,237
-18% -$469K 0.01% 709
2021
Q2
$3.36M Buy
+40,538
New +$3.02M 0.03% 411
2021
Q1
Sell
-65,649
Closed -$5.04M 2669
2020
Q4
$5.04M Buy
+65,649
New +$4.2M 0.1% 152
2020
Q1
Sell
-299,297
Closed -$19M 758
2019
Q4
$19M Buy
+299,297
New +$14.9M 0.82% 18
2019
Q3
Sell
-10,173
Closed -$269K 1383
2019
Q2
$269K Buy
+10,173
New +$223K 0.02% 567
2019
Q1
Sell
-27,593
Closed -$342K 504
2018
Q4
$342K Buy
+27,593
New +$377K 0.05% 309

Other funds holding ARWR

HRT Financial's ARWR Position: Q2 2025 in Review

HRT Financial sold out of Arrowhead Research (ARWR) in Q2 2025, closing a stake of 73,577 shares — an estimated $937K sold.

HRT Financial first reported a position in ARWR in Q4 2018 and held it in 14 quarters. The position peaked at $19M in Q4 2019. 282 funds tracked by Wall St. Rank hold ARWR as of Q2 2025.

  • HRT Financial reported no remaining Arrowhead Research position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 73,577 Arrowhead Research shares in Q2 2025, an estimated $937K.
  • HRT Financial first reported a position in Arrowhead Research in Q4 2018 and held it in 14 quarters.
  • HRT Financial's Arrowhead Research position peaked at $19M in Q4 2019.
  • 282 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.